ArticleInternational journal of surgery (London, England)2025
Neuroendoscopy for acute severe neurological conditions: high hematoma clearance and rapid recovery in 815 patients - cohort study.
Article in International journal of surgery (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative effectiveness of neuroendoscopic surgery and stereotactic aspiration for brain hemorrhage.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the efficacy and safety of neuroendoscopy for acute severe neurological conditions, focusing on hematoma clearance and consciousness recovery.
methodsWe retrospectively analyzed 815 patients who underwent transcranial burr-hole neuroendoscopic surgery at our institution from September 2018 to June 2024 for intracerebral hemorrhage (ICH, n = 474), hemorrhagic cerebrovascular diseases (n = 248), traumatic intracranial hemorrhage (TICH, n = 78), and intraventricular hemorrhage (IVH) with acute hydrocephalus (n = 15). Outcomes included hematoma clearance (via postoperative computed tomography [CT] within 24 hours), consciousness recovery (Glasgow Coma Scale [GCS] ≥9 within 72 hours), complications, and 6-month Glasgow Outcome Scale (GOS) scores.
resultsIn this cohort (n = 815), mean hematoma clearance was 92.3 ± 5.1% (95% CI: 91.8-92.8). Severe complications (e.g., infection, re-bleeding, 30-day mortality) occurred in 3.7% (30/815; 95% CI: 2.5-5.2). Consciousness recovery (GCS ≥9) was achieved in 89.0% (725/815; 95% CI: 86.7-91.1) within 72 hours, and 88.6% (692/781; 95% CI: 86.2-90.7) attained GOS ≥4 at 6 months. Subgroup analyses by age, sex, and baseline severity showed consistent efficacy in hematoma clearance and consciousness recovery. Minor complications (e.g., transient fever, cerebrospinal fluid [CSF] leak) affected 3.1% (25/815; 95% CI: 2.0-4.6).
conclusionNeuroendoscopy provides high hematoma clearance and rapid consciousness recovery with low complication rates, offering potential advantages over traditional craniotomy based on literature comparisons. Further prospective studies are needed to optimize techniques and validate long-term benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.